Related Experiment Video
Updated: May 30, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
A hypertension gene: are we there yet?
Samantha J Lupton1, Christine L Chiu, Joanne M Lind
1Unit of Molecular Physiology, School of Medicine, University of Western Sydney, Australia.
Essential hypertension, a major risk factor for cardiovascular disease, is influenced by genetics. Research shows multiple common genetic variants, not single gene polymorphisms, contribute to high blood pressure risk.
Area of Science:
- Cardiovascular research
- Genetics
- Pharmacogenomics
Background:
- Cardiovascular diseases are the leading global cause of mortality.
- Essential hypertension is a significant risk factor for cardiovascular diseases.
- Genetic factors contribute substantially to blood pressure variability.
Purpose of the Study:
- To review candidate gene and genome-wide association studies in hypertension research.
- To understand the genetic basis of essential hypertension.
- To explore the potential of pharmacogenomics in personalized hypertension treatment.
Main Methods:
- Review of candidate gene association studies.
- Analysis of genome-wide association studies (GWAS).
- Exploration of genetic polymorphisms related to blood pressure regulation.
Main Results:
- Identified numerous polymorphisms increasing hypertension risk.
- Evidence suggests polygenic inheritance for hypertension.
- No single gene polymorphism universally causes hypertension.
Conclusions:
- Hypertension results from the cumulative effect of common genetic variants.
- Personalized pharmacogenomic approaches offer promise for effective hypertension management.
- Tailored treatments can reduce cardiovascular events and societal disease burden.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Pharmacogenomics: Identification of New Drug Targets
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
